Related Experiment Video
Updated: Jun 20, 2026

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis
Carol M Aherne1, Jason McMorrow, David Kane
1College of Life Sciences, UCD Veterinary Sciences Centre, University College Dublin, Belfield, Dublin 4, Ireland.
Abstract:
Expression of the orphan nuclear receptor NR4A2 is controlled by pro-inflammatory mediators, suggesting that NR4A2 may contribute to pathological processes in the inflammatory lesion. This study identifies the chemoattractant protein, interleukin 8 (IL-8/CXCL8), as a molecular target of NR4A2 in human inflammatory arthritis and examines the mechanism through which NR4A2 modulates IL-8 expression. In TNF-alpha-activated human synoviocyte cells, enhanced expression of IL-8 mRNA and protein correspond to temporal changes in NR4A2 transcription and nuclear distribution. Ectopic expression of NR4A2 leads to robust changes in endogenous IL-8 mRNA levels and co-treatment with TNF-alpha results in significant (p<0.001) secretion of IL-8 protein. Transcriptional effects of NR4A2 on the human IL-8 promoter are enhanced in the presence of TNF-alpha, suggesting molecular crosstalk between TNF-alpha signalling and NR4A2. A dominant negative IkappaB kinase antagonizes the combined effects of NR4A2 and TNF-alpha on IL-8 promoter activity. Co-expression of NR4A2 and the p65 subunit of NF-kappaB enhances IL-8 transcription and functional studies indicate that transactivation occurs independently of NR4A2 binding to DNA or heterodimerization with additional nuclear receptors. The IL-8 minimal promoter region is sufficient to support NR4A2 and NF-kappaB/p65 co-operative activity and NR4A2 can interact with NF-kappaB/p65 on a 39bp sequence within this region. In patients treated with methotrexate for active inflammatory arthritis, a reduction in NR4A2 synovial tissue levels correlate significantly (n=10, r=0.73, p=0.002) with changes in IL-8 expression. Collectively, these data delineate an important role for NR4A2 in modulating IL-8 expression and reveal novel transcriptional responses to TNF-alpha in human inflammatory joint disease.
Insights
Nuclear receptor NR4A2 targets interleukin-8 (IL-8) in inflammatory arthritis. NR4A2 and NF-kappaB/p65 co-operatively regulate IL-8, impacting inflammatory joint disease progression.
Area of Science:
- Molecular Biology
- Immunology
- Rheumatology
Background:
- Pro-inflammatory mediators control orphan nuclear receptor NR4A2 expression.
- NR4A2's role in inflammatory lesions suggests involvement in pathological processes.
Purpose of the Study:
- Identify chemoattractant protein IL-8 (CXCL8) as an NR4A2 target in human inflammatory arthritis.
- Examine the mechanism of NR4A2-mediated IL-8 expression modulation.
Main Methods:
- Analyzed NR4A2 and IL-8 expression in TNF-alpha-activated human synoviocytes.
- Investigated NR4A2's transcriptional effects on the IL-8 promoter.
- Assessed NR4A2 interaction with NF-kappaB/p65.
- Correlated NR4A2 levels with IL-8 expression in arthritis patients.
Main Results:
- Enhanced IL-8 mRNA and protein expression correlated with NR4A2 changes in synoviocytes.
- Ectopic NR4A2 expression increased IL-8 levels, potentiated by TNF-alpha.
- NR4A2 and NF-kappaB/p65 co-operatively enhanced IL-8 transcription via a 39bp promoter region.
- Reduced NR4A2 levels in patients correlated with altered IL-8 expression.
Conclusions:
- NR4A2 plays a significant role in modulating IL-8 expression in inflammatory arthritis.
- Novel transcriptional regulation of IL-8 by TNF-alpha and NR4A2 in joint disease identified.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins